499 related articles for article (PubMed ID: 33483498)
1. CRISPR technologies and the search for the PAM-free nuclease.
Collias D; Beisel CL
Nat Commun; 2021 Jan; 12(1):555. PubMed ID: 33483498
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
3. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
[TBL] [Abstract][Full Text] [Related]
4. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
[TBL] [Abstract][Full Text] [Related]
5. Programming PAM antennae for efficient CRISPR-Cas9 DNA editing.
Wang F; Hao Y; Li Q; Li J; Zhang H; Zhang X; Wang L; Bustamante C; Fan C
Sci Adv; 2020 May; 6(19):eaay9948. PubMed ID: 32494703
[TBL] [Abstract][Full Text] [Related]
6. CRISPcut: A novel tool for designing optimal sgRNAs for CRISPR/Cas9 based experiments in human cells.
Dhanjal JK; Radhakrishnan N; Sundar D
Genomics; 2019 Jul; 111(4):560-566. PubMed ID: 29605634
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.
Hibshman GN; Bravo JPK; Hooper MM; Dangerfield TL; Zhang H; Finkelstein IJ; Johnson KA; Taylor DW
Nat Commun; 2024 Apr; 15(1):3663. PubMed ID: 38688943
[TBL] [Abstract][Full Text] [Related]
8. Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a.
Olivi L; Bagchus C; Pool V; Bekkering E; Speckner K; Offerhaus H; Wu WY; Depken M; Martens KJA; Staals RHJ; Hohlbein J
Nucleic Acids Res; 2024 May; 52(9):5241-5256. PubMed ID: 38647045
[TBL] [Abstract][Full Text] [Related]
9. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.
Maxwell CS; Jacobsen T; Marshall R; Noireaux V; Beisel CL
Methods; 2018 Jul; 143():48-57. PubMed ID: 29486239
[TBL] [Abstract][Full Text] [Related]
10. Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM.
Liu Y; Liang F; Dong Z; Li S; Ye J; Qin W
Cells; 2021 Aug; 10(8):. PubMed ID: 34440868
[TBL] [Abstract][Full Text] [Related]
11. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
12. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
Kim D; Luk K; Wolfe SA; Kim JS
Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
[TBL] [Abstract][Full Text] [Related]
13. Engineered dual selection for directed evolution of SpCas9 PAM specificity.
Goldberg GW; Spencer JM; Giganti DO; Camellato BR; Agmon N; Ichikawa DM; Boeke JD; Noyes MB
Nat Commun; 2021 Jan; 12(1):349. PubMed ID: 33441553
[TBL] [Abstract][Full Text] [Related]
14. A pipeline for characterization of novel Cas9 orthologs.
Karvelis T; Young JK; Siksnys V
Methods Enzymol; 2019; 616():219-240. PubMed ID: 30691644
[TBL] [Abstract][Full Text] [Related]
15. Advances in Accurate Microbial Genome-Editing CRISPR Technologies.
Lee HJ; Lee SJ
J Microbiol Biotechnol; 2021 Jul; 31(7):903-911. PubMed ID: 34261850
[TBL] [Abstract][Full Text] [Related]
16. Automated identification of sequence-tailored Cas9 proteins using massive metagenomic data.
Ciciani M; Demozzi M; Pedrazzoli E; Visentin E; Pezzè L; Signorini LF; Blanco-Miguez A; Zolfo M; Asnicar F; Casini A; Cereseto A; Segata N
Nat Commun; 2022 Oct; 13(1):6474. PubMed ID: 36309502
[TBL] [Abstract][Full Text] [Related]
17. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM.
Endo M; Mikami M; Endo A; Kaya H; Itoh T; Nishimasu H; Nureki O; Toki S
Nat Plants; 2019 Jan; 5(1):14-17. PubMed ID: 30531939
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
Moreb EA; Hutmacher M; Lynch MD
CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
[TBL] [Abstract][Full Text] [Related]
19. Inconclusive studies on possible CRISPR-Cas off-targets should moderate expectations about enzymes that have evolved to be non-specific.
Chakraborty S
J Biosci; 2018 Jun; 43(2):225-228. PubMed ID: 29872009
[No Abstract] [Full Text] [Related]
20. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
